We recently published a list of 10 Small–Cap Stocks Insiders Are Selling Recently. In this article, we are going to take a look at where Travere Therapeutics, Inc. (NASDAQ:TVTX) stands against other ...

Guggenheim analyst Vamil Divan raised the firm’s price target on Travere Therapeutics (TVTX) to $47 from $45 and keeps a Buy rating on the ...

Travere Therapeutics (NASDAQ:TVTX – Get Free Report) had its target price hoisted by equities researchers at Canaccord Genuity Group from $22.00 to $45.00 in a research report issued on ...

The webcast and dial-in information can be accessed on the Investor page of Travere's website at ir.travere.com/events-presentations . Following the live webcast, an archived version of the call will ...

In a report released today, Laura Chico from Wedbush maintained a Hold rating on Ultragenyx Pharmaceutical (RARE – Research Report), with a ...

DUBLIN-- ( BUSINESS WIRE )--The "2025 MedDev AI Marketing Summit (San Diego, CA, United States - February 27-28, 2025)" has been added to ResearchAndMarkets.com's offering.

As global markets navigate a landscape of tariff uncertainties and mixed economic signals, with the S&P 500 Index showing resilience despite recent declines, investors are closely monitoring how these ...

Over the last 7 days, the United States market has remained flat, yet it is up 21% over the past year with earnings forecast to grow by 14% annually. In this context, identifying high growth tech ...